Predicting early relapse in patients with multiple myeloma
At the 25th European Hematology Association (EHA) Annual Congress, three posters outlined the latest advancements achieved by GIMEMA, the Italian Adult Hematological Diseases Group, in predicting ER and survival outcomes for patients with MM. The Multiple Myeloma Hub is pleased to provide a summary.